Estimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE study

OBJECTIVE: To measure and value the impact of combined etanercept (ETN) and methotrexate (MTX) therapy on work productivity in patients with early rheumatoid arthritis (RA) over 52 weeks. METHODS: MTX- and biological-naïve patients with RA (symptom onset ≤12 months; Disease Activity Score based on a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Bansback, Nick, Sun, Huiying, Pedersen, Ronald, Kotak, Sameer, Anis, Aslam H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613161/
https://www.ncbi.nlm.nih.gov/pubmed/26535135
http://dx.doi.org/10.1136/rmdopen-2014-000042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613161/
https://www.ncbi.nlm.nih.gov/pubmed/26535135
http://dx.doi.org/10.1136/rmdopen-2014-000042

Ejemplares similares